Form 4: Intuitive Surgical Executive Stock Sale

Mark Brosius, EVP of Manufacturing and Supply Chain at Intuitive Surgical, sold 69 shares of common stock via a 10b5-1 plan.

Summary

• Mark Brosius, EVP & Chief Manufacturing and Supply Chain Officer, executed a series of stock sales between June 8, 2026, and June 10, 2026.
• A total of 69 shares of Intuitive Surgical (ISRG) common stock were sold.
• The sales were conducted at prices ranging from $420.12 to $424.14 per share.
• Following these transactions, the reporting person retains 1,454 shares of common stock.
• The transactions were executed pursuant to a pre-established Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were pre-planned and represent a very small portion of the executive's holdings.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell stock without triggering insider trading concerns.

Negatives

• The filing reflects a reduction in the executive's direct equity stake in the company.

Risks

• None identified; this is a routine disclosure of executive equity transactions.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of executive equity transactions.

Industry Context

StockSavvy.ai notes that routine 10b5-1 sales by high-level executives are common in the medical technology sector and generally do not signal a change in corporate strategy or outlook.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate officers at large-cap companies like Intuitive Surgical to manage personal liquidity.
• The volume of shares sold is negligible relative to the total outstanding shares of Intuitive Surgical.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was pre-planned and small in scale.

Next Steps

• No further actions required; the trading plan remains in effect until February 14, 2027.

Key Dates

Keywords

Intuitive Surgical, ISRG, Insider Trading, Form 4, Executive Stock Sale, Rule 10b5-1